Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:17 pm Purchase | 2025-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Woodline Partners LP | 4,504,817 7.300% | 4,504,817 (New Position) | Filing History |
| 2025-11-14 08:22 am Sale | 2025-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Deep Track Capital LP | 0 0.000% | -3,947,807 (Position Closed) | Filing History |
| 2025-09-04 5:13 pm Purchase | 2025-08-27 | 13G | Pliant Therapeutics, Inc. PLRX | Point72 Asset Management, L.P. | 4,085,017 6.700% | 4,085,017 (New Position) | Filing History |
| 2025-08-14 08:49 am Sale | 2025-06-30 | 13G | Pliant Therapeutics, Inc. PLRX | Deep Track Capital LP | 3,947,807 6.430% | -1,802,193 (-31.34%) | Filing History |
| 2025-08-06 2:12 pm Purchase | 2025-06-30 | 13G | Pliant Therapeutics, Inc. PLRX | MORGAN STANLEY MS | 3,737,335 6.100% | 3,737,335 (New Position) | Filing History |
| 2025-07-29 2:22 pm Sale | 2025-06-30 | 13G | Pliant Therapeutics, Inc. PLRX | VANGUARD GROUP INC | 3,002,348 4.890% | -63,521 (-2.07%) | Filing History |
| 2025-07-17 8:12 pm Sale | 2025-06-30 | 13G | Pliant Therapeutics, Inc. PLRX | BlackRock Inc. BLK | 2,104,574 3.400% | -2,696,943 (-56.17%) | Filing History |
| 2025-05-15 4:39 pm Sale | 2025-03-31 | 13G | Pliant Therapeutics, Inc. PLRX | Paradigm BioCapital Advisors LP | 0 0.000% | -3,059,411 (Position Closed) | Filing History |
| 2025-05-14 10:45 am Sale | 2025-03-31 | 13G | Pliant Therapeutics, Inc. PLRX | T. Rowe Price Associates, Inc. | 87,674 0.100% | -4,747,139 (-98.19%) | Filing History |
| 2025-03-10 5:24 pm Purchase | 2025-03-03 | 13D | Pliant Therapeutics, Inc. PLRX | TANG CAPITAL MANAGEMENT, LLC | 5,859,044 9.600% | 5,859,044 (New Position) | Filing History |
| 2025-03-07 10:01 am Sale | 2025-02-28 | 13G | Pliant Therapeutics, Inc. PLRX | FMR LLC | 131,993 0.200% | -3,831,424 (-96.67%) | Filing History |
| 2025-02-14 8:01 pm Sale | 2024-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 2,895,478 4.800% | -302,013 (-9.45%) | Filing History |
| 2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Redmile Group, LLC | 3,197,491 5.300% | 500,843 (+18.57%) | Filing History |
| 2024-11-14 5:05 pm Unchanged | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Blue Owl Capital Holdings LP | 3,004,199 4.940% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:47 pm Sale | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | First Light Asset Management, LLC | 1,951,467 3.210% | -1,726,543 (-46.94%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | T. Rowe Price Associates, Inc. | 4,834,813 8.000% | 1,046,697 (+27.63%) | Filing History |
| 2024-11-12 11:53 am Sale | 2024-09-30 | 13G | Pliant Therapeutics, Inc. PLRX | Laurion Capital Management LP | 0 0.000% | -3,583,567 (Position Closed) | Filing History |
| 2024-10-04 5:34 pm Purchase | 2024-09-24 | 13G | Pliant Therapeutics, Inc. PLRX | Paradigm BioCapital Advisors LP | 3,059,411 5.030% | 3,059,411 (New Position) | Filing History |
| 2024-02-14 8:55 pm Purchase | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Blue Owl Capital Holdings LP | 3,004,199 5.020% | 3,004,199 (New Position) | Filing History |
| 2024-02-14 5:10 pm Purchase | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | First Light Asset Management, LLC | 3,678,010 6.140% | 3,678,010 (New Position) | Filing History |